Position in OVID
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$50,728
+$8,864 QoQ
Shares Held
18,858
0.0% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#94
of 129 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OVID Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TLS Advisors LLC holds $1,919,232 across 4 Biotechnology names. OVID ranks #2 (2.6% of the industry book) .
All Filings in OVID
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $50,728 | 18,858 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $41,864 | 18,858 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $374 | 13,600 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $24,515 | 18,858 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $224,719 | 680,967 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $212,461 | 680,967 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $636,023 | 680,967 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $910,406 | 771,531 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $865,352 | 1,125,296 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $4,025,020 | 1,319,679 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $4,249,366 | 1,319,679 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,067,567 | 1,319,679 | Shares | Sole | 2023-11-16 | |
| 2023-06-30 | $4,328,547 | 1,319,679 | Shares | Sole | 2023-11-16 | |
| 2023-03-31 | $3,561,292 | 1,380,346 | Shares | Sole | 2023-11-16 | |
| 2022-12-31 | $2,772,393 | 1,490,534 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||